| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/26/2008 | WO2008075117A1 Apovincaminic acid or its ethyl ester derivative for the treatment of microangiopathies |
| 06/26/2008 | WO2008075110A1 Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety |
| 06/26/2008 | WO2008075109A1 Substituted piperidines having protein kinase inhibiting activity |
| 06/26/2008 | WO2008075104A1 Modulators of beta-2-adrenergic receptor for treating conditions characterized by disorganized vasculature |
| 06/26/2008 | WO2008075103A1 Antiviral indoles |
| 06/26/2008 | WO2008075102A1 Pharmaceutical compositions for transmucusal delivery of a therapeutically active agent on the basis of submicron particles |
| 06/26/2008 | WO2008075077A1 Piperidine derivatives for the treatment of obesity |
| 06/26/2008 | WO2008075073A1 Novel crystalline compound useful as glk activator |
| 06/26/2008 | WO2008075064A1 Piperidine derivatives for the treatment of obesity |
| 06/26/2008 | WO2008075048A2 Polyalkyloxydibenz ( c, e) oxepine derivatives as medicaments |
| 06/26/2008 | WO2008075042A1 Combination comprising cndac (2'-cyano-2'-deoxy-n4-palmitoyl-1-beta-d-arabinofuranosyl-cytosine) and a cytotoxic agent |
| 06/26/2008 | WO2008075028A1 New combination for use in the treatment of inflammatory disorders |
| 06/26/2008 | WO2008075025A1 Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases |
| 06/26/2008 | WO2008075019A1 Modulators of cb1 receptors |
| 06/26/2008 | WO2008075013A1 Modulators of cannabinoid receptor |
| 06/26/2008 | WO2008075012A1 Cb1 receptor modulators |
| 06/26/2008 | WO2008075007A1 Morpholino-substituted bicycloheteroaryl compounds and their use as anti cancer agents |
| 06/26/2008 | WO2008075005A1 Quinuclidinol derivatives as muscarinic receptor antagonists |
| 06/26/2008 | WO2008074997A1 Pyridine benzamides and pyrazine benzamides used as pkd inhibitors |
| 06/26/2008 | WO2008074982A1 Pyrazole derivatives as modulators of cannabinoid receptor |
| 06/26/2008 | WO2008074975A1 New combination for use in the treatment of inflammatory disorders |
| 06/26/2008 | WO2008074966A1 Crth2 antagonists |
| 06/26/2008 | WO2008074935A2 Biologically active compositions, methods for producing the same and biological applications |
| 06/26/2008 | WO2008074885A2 Process for manufacturing ophthalmic oil-in-water emulsions |
| 06/26/2008 | WO2008074860A1 Pharmaceutical composition comprising nicotinamide or nicotinic acid |
| 06/26/2008 | WO2008074856A1 Combination therapy for the treatment of airways disease |
| 06/26/2008 | WO2008074853A1 Ophthalmic rebamipide solution |
| 06/26/2008 | WO2008074849A1 Method of using fluocinolone acetonide, tretinoin and hydroquinone cream in melasma maintenance therapy |
| 06/26/2008 | WO2008074848A1 Method of using fluocinolone acetonide, tretinoin and hydroquinone cream in melasma maintenance therapy |
| 06/26/2008 | WO2008074835A1 2-substituted 5-membered heterocycles as scd inhibitors |
| 06/26/2008 | WO2008074834A2 Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase (scd) |
| 06/26/2008 | WO2008074833A2 Compounds |
| 06/26/2008 | WO2008074832A2 Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase ( scd) |
| 06/26/2008 | WO2008074824A2 Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase (scd) |
| 06/26/2008 | WO2008074821A1 Indole derivatives as s1p1 receptor agonists |
| 06/26/2008 | WO2008074820A1 Oxadiazole derivatives as s1p1 receptor agonists |
| 06/26/2008 | WO2008074816A1 Compounds with a combination of cannabinoid-cb1 antagonism and acetylcholinesterase inhibition |
| 06/26/2008 | WO2008074814A1 Pyrazole derivatives as non-steroidal glucocorticoid receptor ligands |
| 06/26/2008 | WO2008074798A1 Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/26/2008 | WO2008074797A1 Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/26/2008 | WO2008074795A1 Sulfated benzimidazolone derivatives having mixed serotonine receptor affinity |
| 06/26/2008 | WO2008074788A1 Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors |
| 06/26/2008 | WO2008074756A1 Novel biphenyl thio-urea derivatives useful as potassium channel modulators |
| 06/26/2008 | WO2008074755A2 Novel cinnamic amide derivatives useful as ion channel modulators |
| 06/26/2008 | WO2008074752A2 Indolylmaleimide derivatives as kinase inhibitors |
| 06/26/2008 | WO2008074749A1 Indazole derivatives as kinase inhibitors for the treatment of cancer |
| 06/26/2008 | WO2008074723A1 Inclusion complex of ezetimibe and a cyclodextrin and processes in the preparation thereof |
| 06/26/2008 | WO2008074716A1 Azabicyclic compounds as serotonine, dopamine and norepinephrine re-uptake inhibitors |
| 06/26/2008 | WO2008074703A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
| 06/26/2008 | WO2008074697A1 Polymorphs of a mglur5 receptor antagonist |
| 06/26/2008 | WO2008074694A1 Crystallization of glucokinase activators |
| 06/26/2008 | WO2008074692A1 Sulfonamide derivatives as liver carnitine palmitoyl transferase (l-cptl ) |
| 06/26/2008 | WO2008074679A2 4-imidazolines as taar's ligands |
| 06/26/2008 | WO2008074678A1 Novel use of inhibitors of soluble epoxide hydrolase |
| 06/26/2008 | WO2008074676A1 Pyrazolo [3, 4 -d] pyrimidine p38 map kinase inhibitors |
| 06/26/2008 | WO2008074573A1 Topical dosage form comprising tri-substituted glycerol compounds |
| 06/26/2008 | WO2008074572A1 Use of tri-substituted glycerol compounds for the treatment of hematological malignancies |
| 06/26/2008 | WO2008074515A1 Novel hetaryl-phenylene-diamine pyrimidine as protein kinase inhibitors |
| 06/26/2008 | WO2008074479A1 Gelatin capsules comprising an acid |
| 06/26/2008 | WO2008074450A2 Non-peptidic renin inhibitors nitroderivatives |
| 06/26/2008 | WO2008074445A1 Novel tricyclic and heterotricyclic derivatives, processes for preparing them, pharmaceutical compositions thereof |
| 06/26/2008 | WO2008074420A1 Plants extracts for use in brain modulation |
| 06/26/2008 | WO2008074419A1 Dosage form comprising immediate release naproxen and sustained release opioid analgesic |
| 06/26/2008 | WO2008074413A2 Heteroarylacrylamides and their use as pharmaceuticals for the stimulation of the expression of endothelial no synthase |
| 06/26/2008 | WO2008074384A1 2-ADAMANTYL-BUTYRAMIDE DERIVATIVES AS SELECTIVE 11βETA-HSD1 INHIBITORS |
| 06/26/2008 | WO2008074267A2 Liposomal gel phthalocyanine preparation for photodynamic therapy of tumors and its manufacturing |
| 06/26/2008 | WO2008074253A1 Pyridazinoindole derivatives, their preparation and therapy use |
| 06/26/2008 | WO2008074227A1 Synthetic ion channels |
| 06/26/2008 | WO2008074145A1 Pharmaceutical composition comprising a hot-melt granulated lubricant |
| 06/26/2008 | WO2008074144A1 A composition containing a bisphosphonic acid in combination with vitamin d |
| 06/26/2008 | WO2008074132A1 Inhibitors of histone deacetylase and prodrugs thereof |
| 06/26/2008 | WO2008074108A2 Controlled release pharmaceutical composition of anti-hyperglycemic agent and its preparation |
| 06/26/2008 | WO2008074098A1 Pharmaceutical composition |
| 06/26/2008 | WO2008074097A1 Pharmaceutical compound and composition |
| 06/26/2008 | WO2008074091A1 Radioprotector compounds and related methods |
| 06/26/2008 | WO2008074078A1 Selectively deliverable isatin-based cytotoxic agents |
| 06/26/2008 | WO2008074068A1 Substituted quinoline derivatives as antiamyloidogeneic agents |
| 06/26/2008 | WO2008058126A3 Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors |
| 06/26/2008 | WO2008058096A9 Azaadamantane derivatives and their uses as nicotinic acetylcholine receptors ligands |
| 06/26/2008 | WO2008057930A3 Methods of treating neuropathic pain with retinoic acid receptor agonists |
| 06/26/2008 | WO2008057601A3 Organic compounds |
| 06/26/2008 | WO2008057512A3 Imidazopyrazines as protein kinase inhibitors |
| 06/26/2008 | WO2008054435A3 Use of sk channel activators to prevent relapse/reinstatement of drugs of abuse |
| 06/26/2008 | WO2008053270A3 Use of an egfr antagonist for the treatment of glomerolonephritis |
| 06/26/2008 | WO2008052005A3 Compounds and methods for treating estrogen receptor-related diseases |
| 06/26/2008 | WO2008051557A9 Methods and compositions for treatment of skin conditions |
| 06/26/2008 | WO2008049078B1 Nicked or gapped nucleic acid molecules and uses thereof |
| 06/26/2008 | WO2008047201A3 Solid dispersion comprising a poorly water soluble drug |
| 06/26/2008 | WO2008045330A3 Effective delivery of cross-species a3 adenosine-receptor antagonists to reduce intraocular pressure |
| 06/26/2008 | WO2008043829A3 Method for treating hiv-1 infection by the combined administration of nevirapine, tenofovir and emtricitabine |
| 06/26/2008 | WO2008043733B1 3- (benzo [d] [1,3] dioxol-5-ylmethyl) -4- (thio) oxo-2- (thio) oxo-azolidin-5-ylidene derivatives as antibacterial agents |
| 06/26/2008 | WO2008041514A9 Radiation sensitizer or anti-cancer chemotherapy sensitizer |
| 06/26/2008 | WO2008040550A3 Olive extracts for promoting muscle health |
| 06/26/2008 | WO2008038251A3 3-aza-bicyclo[3.1.0]hexane derivatives |
| 06/26/2008 | WO2008038003A3 Pharmaceutical compositions of aripiprazole |
| 06/26/2008 | WO2008036733A3 Methods for treatment of vesicle transport disorders |
| 06/26/2008 | WO2008036247A8 Renin inhibitors |
| 06/26/2008 | WO2008034644A3 Process for making anastrozole |
| 06/26/2008 | WO2008030604A3 Treatment, prevention, and reversal of alcohol-induced brain disease |
| 06/26/2008 | WO2008030557A9 Compositions and methods for enhancing transport through mucus |